Profile
Pierre Brégeard formerly worked at Stentys SA, as Chief Technology Officer from 2017 to 2020.
Mr. Brégeard received his graduate degree from Université de Lorraine.
Former positions of Pierre Brégeard
| Companies | Position | End |
|---|---|---|
| STENTYS | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Training of Pierre Brégeard
| Université de Lorraine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
- Stock Market
- Insiders
- Pierre Brégeard
